Table 3.
Demographic, clinical, biochemical and angiographic characteristics in low and high SYNTAX score II group
| Variables | SS II ≤ 25.4 (n = 100) | SS II > 25.4 (n = 101) | P value |
|---|---|---|---|
| Age, years | 57 (50–65) | 70 (65–75) | < .001 |
| Male gender, n (%) | 85 (85.0%) | 51 (50.5%) | < .001 |
| Hypertension, n (%) | 57 (57.0%) | 70 (69.3%) | .070 |
| Diabetes, n (%) | 28 (23.0%) | 21 (20.8%) | .234 |
| Smoking, n (%) | 23 (25.0%) | 7 (6.9%) | .001 |
| COPD, n (%) | 2 (2.0%) | 2 (2.0%) | 1.0 |
| PAD, n (%) | 5 (5.0%) | 8 (7.9%) | .400 |
| BMI, kg/m2 | 25.7 ± 3.6 | 23.9 ± 2.9 | < .001 |
| WBC, 109/L | 6.7 (5.5–8.4) | 6.5 (5.3–8.0) | .383 |
| NEUT, 109/L | 4.1 (3.4–5.4) | 4.1 (3.4–5.7) | .964 |
| LYM, 109/L | 1.9 (1.4–2.2) | 1.6 (1.2–2.0) | .007 |
| NLR | 2.3 (1.7–3.3) | 2.6 (2.0–3.5) | .069 |
| Platelet, 109/L | 188 (148–222) | 162 (140–210) | .061 |
| RDW | 12.8 (12.5–13.3) | 13.0 (12.6–13.5) | .053 |
| Hemoglobin, g/L | 135.3 ± 15.4 | 123.7 ± 15.4 | < .001 |
| IL-6, pg/ml | 6.6 (3.8–9.2) | 8.2 (5.2–14.4) | .002 |
| hs-CRP, mg/l | 5.7 (1.2–10.1) | 6.2 (2.4–14.7) | .087 |
| Glucose, mmol/L | 5.8 ± 2.8 | 5.5 ± 1.8 | .336 |
| TC, mmol/L | 4.0 ± 1.0 | 3.9 ± 1.0 | .552 |
| Triglyceride, mmol/L | 1.5 (1.0–2.0) | 1.3 (1.0–1.9) | .439 |
| HDL-c, mmol/L | 1.2 (1.0–1.4) | 1.2 (1.1–1.4) | .213 |
| LDL-c, mmol/L | 2.2 ± 0.7 | 2.2 ± 0.8 | .715 |
| apoB, g/L | 0.8 (0.6–1.0) | 0.8 (0.6–0.9) | .662 |
| apoA1, g/L | 1.0 ± 0.2 | 1.1 ± 0.2 | .321 |
| Creatinine, umol/L | 68.4 (59.2–79.6) | 72.0 (55.4–92.7) | .237 |
| eGFR, ml/min | 103.9 (86.1–126.9) | 69.9 (53.9–88.8) | < .001 |
| Albumin, g/L | 39.9 (38.4–42.2) | 38.1 (36.1–40.5) | < .001 |
| Fibrinogen, g/L | 3.0 (2.5–3.6) | 3.2 (2.7–4.0) | .041 |
| D-Dimer, ug/ml | 0.3 (0.2–0.4) | 0.4 (0.2–0.7) | .001 |
| LVEF, % | 63.0 (59.0–65.0) | 62.0 (50.0–65.0) | .050 |
| SS | 11.0 (7.0–16.0) | 15.0 (9.0–22.0) | < .001 |
| SS II | 20.8 (17.8–22.9) | 32.3 (28.6–38.1) | < .001 |
| rSS | 2.0 (0–5.4) | 4.0 (0–9.0) | .161 |
BMI, Body Mass Index; WBC, white blood cell; NEUT, neutrophil; LYM, lymphocyte; NLR, the neutrophil to the lymphocyte ratio; RDW, red cell distribution width; IL-6, interleukin 6; hs-CRP, high-sensitivity C-reactive protein; TC, total cholesterol; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; apoB, apolipoprotein B; apoA1, apolipoprotein A1; apoB/apoA1, the apoB to the apoA1 ratio; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; SYNTAX, SYNergy between Percutaneous Coronary Intervention with TAXus and cardiac surgery; SS, SYNTAX score; SS II, SYNTAX score II